查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1650776

全球生物庫市場

Biobanks
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 402 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年全球生物銀行市場規模將達到 1,433 億美元

2024 年全球生物銀行市場規模估計為 916 億美元，預計到 2030 年將達到 1,433 億美元，2024-2030 年分析期間的複合年成長率為 7.7%。物理/真實生物庫是報告中分析的部分之一，預計到分析期結束時複合年成長率為 7.3%，達到 1084 億美元。在分析期內，虛擬生物庫部分預計將以 9.2% 的複合年成長率成長。

美國市場預計將達到 298 億美元，中國市場年複合成長率將達 8.8%

預計2024年美國生物銀行市場規模將達298億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 151 億美元，2024-2030 年分析期間的複合年成長率為 8.8%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 6.5% 和 7.0%。在歐洲，德國的複合年成長率預計為 7.6%。

全球生物銀行市場 - 主要趨勢和促進因素摘要

生物庫是一個專門的儲存庫，用於收集、儲存和管理血液、組織、DNA 和其他體液等生物樣本，供研究和臨床研究使用。這些樣本以及相關資料是推動醫學研究、了解疾病和開發新治療方法和診斷方法的寶貴資源。生物庫支持廣泛的研究領域，包括基因組學、個人化醫療、流行病學和轉化研究。它為研究人員提供了研究疾病機制、識別生物標記以及測試新藥和治療方法所必需的高品質、特性良好的檢體。

由於技術和資料管理的進步，生物庫的開發和使用得到了顯著改善。現代生物庫採用先進的系統進行檢體收集、處理、儲存和搜尋，以確保檢體的完整性和可追溯性。高通量定序、生物資訊學和資料分析的整合使得從生物庫樣本中提取有價值的見解成為可能，促進醫學研究的突破。此外，標準化通訊協定和品管措施的實施確保了研究結果的一致性和可重複性。它們還在大規模人口和縱向研究中發揮重要作用，為了解導致健康和疾病的遺傳、環境和生活方式因素提供了基礎。

生物庫市場的成長受到多種因素的推動。首先，癌症和心血管疾病等慢性和複雜疾病的發生率不斷上升，推動了對生物庫的需求，以支持新治療方法和診斷方法的研究。其次，個人化醫療和精準醫療的興起推動了對可用於開發標靶治療和干涉措施的特徵明確的生物樣本的需求。第三，人們對遺傳和基因組研究的日益關注導致了生物庫樣本在研究疾病遺傳基礎和識別新生物標記方面的應用範圍擴大。此外，生物庫技術的進步，包括自動化儲存系統和先進的資料管理平台，正在提高生物庫的效率和容量。最後，增加學術機構、醫療保健組織和產業參與者之間的資金和合作，將支持生物庫的建立和擴張，刺激市場成長並推動生物醫學研究的創新。

部分

類型（物理/真實、虛擬）；產品（生物銀行設備、生物銀行耗材、實驗室資訊管理系統）；應用（治療藥物、藥物發現/臨床研究、臨床診斷、其他應用）

調查企業範例（共99家）

  • AMS Biotechnology（Europe）Limited
  • Bay Biosciences LLC
  • BioIVT & Elevating Science
  • BioLifeSolutions Inc.
  • Biovault Technical
  • CENTOGENE NV
  • CTI Biotech
  • Cureline, Inc.
  • Firalis SA
  • Hamilton Company
  • Merck KGaA
  • ProteoGenex, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • US Biolab Corporation, Inc.
  • VWR International LLC

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP-6861

Global Biobanks Market to Reach US$143.3 Billion by 2030

The global market for Biobanks estimated at US$91.6 Billion in the year 2024, is expected to reach US$143.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$108.4 Billion by the end of the analysis period. Growth in the Virtual Biobanks segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.8 Billion While China is Forecast to Grow at 8.8% CAGR

The Biobanks market in the U.S. is estimated at US$29.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$15.1 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Biobanks Market - Key Trends & Drivers Summarized

Biobanks are specialized repositories that collect, store, and manage biological samples such as blood, tissue, DNA, and other bodily fluids for use in research and clinical studies. These samples, along with associated data, are invaluable resources for advancing medical research, understanding diseases, and developing new treatments and diagnostics. Biobanks support a wide range of research areas, including genomics, personalized medicine, epidemiology, and translational research. They provide researchers with access to high-quality, well-characterized specimens that are critical for studying disease mechanisms, identifying biomarkers, and testing new drugs and therapies.

The development and utilization of biobanks have been significantly enhanced by advancements in technology and data management. Modern biobanks employ sophisticated systems for sample collection, processing, storage, and retrieval, ensuring the integrity and traceability of specimens. The integration of high-throughput sequencing, bioinformatics, and data analytics enables the extraction of valuable insights from biobank samples, facilitating breakthroughs in medical research. Moreover, the implementation of standardized protocols and quality control measures ensures the consistency and reproducibility of research findings. Biobanks also play a crucial role in large-scale population studies and longitudinal research, providing a foundation for understanding the genetic, environmental, and lifestyle factors that contribute to health and disease.

The growth in the biobank market is driven by several factors. Firstly, the increasing prevalence of chronic and complex diseases, such as cancer and cardiovascular disorders, is driving the demand for biobanks to support research into new treatments and diagnostics. Secondly, the rise of personalized medicine and precision healthcare is boosting the need for well-characterized biological samples that can be used to develop targeted therapies and interventions. Thirdly, the growing focus on genetic and genomic research is expanding the use of biobank samples for studying the genetic basis of diseases and identifying novel biomarkers. Additionally, advancements in biobanking technologies, including automated storage systems and advanced data management platforms, are enhancing the efficiency and capabilities of biobanks. Lastly, increased funding and collaboration between academic institutions, healthcare organizations, and industry players are supporting the establishment and expansion of biobanks, driving market growth and fostering innovation in biomedical research.

SCOPE OF STUDY:

The report analyzes the Biobanks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Physical / Real, Virtual); Product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems); Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 99 Featured) -

  • AMS Biotechnology (Europe) Limited
  • Bay Biosciences LLC
  • BioIVT & Elevating Science
  • BioLifeSolutions Inc.
  • Biovault Technical
  • CENTOGENE NV
  • CTI Biotech
  • Cureline, Inc.
  • Firalis S.A.
  • Hamilton Company
  • Merck KGaA
  • ProteoGenex, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • US Biolab Corporation, Inc.
  • VWR International LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Growing Focus on Early Diagnosis and Treatment of Chronic Diseases and Genetic Conditions Cornerstone for the Growth of Biobanks
    • Global Economic Update
    • Competition
    • Biobanks - Global Key Competitors Percentage Market Share in 2024 (E)
    • Biobanks Competitor Market Share Scenario Worldwide (in %): 2022E
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Research Focus on Regenerative Medicine Expands Opportunities for Biobanks
    • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
    • Uptrend in Translational Research and Personalized Medicine to Benefit Demand
    • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Biobanks: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
    • Growing Focus on Personalized Medicine for Oncology Domain Raises the Importance of Biobanking Services
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Biobanks Poised to Benefit from the Increasingly Robust Outlook for Digital Health
    • Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
    • Rise Genomic Research Initiatives Drives Growth Opportunities
    • Technological Advancements Bring in Transformative Changes
    • AI and ML Advancements to Benefit Biobanks
    • Biobanks Enter the Age of Big Data
    • Use of Laboratory Information Management System Software Gains Momentum
    • Biobanks Turn to Customized LIMS Software
    • Biobanking Jumpstarts to a New Era with Imaging Biobanks
    • Imaging Biobanks Dedicated to Radiogenomics
    • Virtual Biobanks Emerge as Bankable Option for Access to Research Resources
    • Strong Outlook for Gene Therapy to Drive Demand for Biobanking Services
    • World Gene Therapy Market in US$ Million:L 2020, 2022, 2024, 2026, 2028, 2030
    • Uptrend in Drug Discovery Research Builds Robust Momentum
    • Global Drug Discovery Market Size (in US$ Billion) for the Years 2020, 2022, 2024, 2026, 2028, ad 2030
    • Human iPSC Banks: A Review of Emerging Opportunities
    • Human iPSC Banks Worldwide: An Overview
    • Automated Storage Systems Gain Importance
    • Prospective Collection to Gather Steam
    • Rise in R&D Initiatives in Life Sciences & Pharmaceutical Industries Boosts Prospects
    • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
    • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Physical / Real by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Physical / Real by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Physical / Real by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Virtual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Virtual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Virtual by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Biobanking Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Biobanking Equipment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Biobanking Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Biobanking Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Biobanking Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Laboratory Information Management Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Laboratory Information Management Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Laboratory Information Management Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Drug Discovery & Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Drug Discovery & Clinical Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Biobanks Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Biobanks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Biobanks by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 80: France Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 107: UK Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biobanks Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Biobanks by Type - Physical / Real and Virtual - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Biobanks by Type - Physical / Real and Virtual Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Biobanks by Type - Percentage Breakdown of Value Revenues for Physical / Real and Virtual for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Biobanks by Product - Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Biobanks by Product - Percentage Breakdown of Value Revenues for Biobanking Equipment, Biobanking Consumables and Laboratory Information Management Systems for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Biobanks by Application - Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Biobanks by Application - Percentage Breakdown of Value Revenues for Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION